ARDS — Aridis Pharmaceuticals Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.01m
- -$0.03m
- $3.09m
Aridis Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Brief: Aridis' Pan-Coronavirus, Inhaled Monoclonal Antibody Cocktail Ar-701 Is Protective In Non-Human Primates
Aridis Pharmaceuticals Inc expected to post a loss of 6 cents a share - Earnings Preview
Brief: Aridis Pharmaceuticals Reports Qtrly Net Loss Per Share Of $0.44
Aridis Pharmaceuticals Inc expected to post a loss of 51 cents a share - Earnings Preview
Aridis Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary
Brief: Aridis Pharmaceuticals Announces 2021 Fourth Quarter And Year-End Financial Results And Business Update
Aridis Pharmaceuticals Inc expected to post a loss of 41 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Gold stocks, Roblox, Tesla, AIG, big banks
U.S. STOCKS ON THE MOVE-Nvidia, Marathon Oil, Palantir Technologies, Hasbro, Walmart
U.S. STOCKS ON THE MOVE-Chip stocks, Visa, AppLovin, DoorDash, AutoNation
Brief: Aridis' Pan-Coronavirus Monoclonal Antibody Cocktail Ar-701 Is Protective In Covid-19 Omicron Infected Animals
Aridis Pharma up as COVID therapy shows promise against Omicron in animal studies
U.S. STOCKS ON THE MOVE-Netflix, Tesla, Intel
U.S. STOCKS ON THE MOVE-Epizyme, National Security, Lendingclub
U.S. STOCKS ON THE MOVE-Epizyme, Aridis Pharma, Netflix, ServiceNow
Aridis Pharma gains on Gates foundation funding for COVID-19 therapy
Brief: Aridis Pharmaceuticals Receives Funding To Evaluate Inhaled Monoclonal Antibodies To Block Influenza And Sars-Cov-2 Transmission
Aridis Pharmaceuticals drops to record low on $25 mln share offering plan